Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why NuVasive Stock Gained 14% in July


Medical device specialist NuVasive (NASDAQ: NUVA) outpaced the market last month by gaining 14% compared to a 1% uptick in the S&P 500, according to S&P Global Market Intelligence. The rally lifted shares to an over-30% return so far in 2019 compared to 16% growth in the broader market.

Image source: Getty Images.

July's rally was sparked by a late-month quarterly earnings announcement that was well received on Wall Street. In that report, the company announced modestly higher sales that met expectations. Earnings growth was more robust than expected, though, on strength in NuVasive's U.S. market.

Continue reading


Source Fool.com

Like: 0
Share

Comments